119 related articles for article (PubMed ID: 16419183)
41. Re: Preventing cervical cancer globally by acting locally: if not now, when?
Suba EJ; Michelow PM; Wright CA; Raab SS
J Natl Cancer Inst; 2011 Apr; 103(7):611-2; author reply 612-3. PubMed ID: 21451154
[No Abstract] [Full Text] [Related]
42. Visualizing cost-effectiveness analysis.
Mark DH
JAMA; 2002 May; 287(18):2428-9. PubMed ID: 11988064
[No Abstract] [Full Text] [Related]
43. HPV screening offers greater protection against invasive cervical cancer than cytology, finds analysis.
Kmietowicz Z
BMJ; 2013 Nov; 347():f6624. PubMed ID: 24191217
[No Abstract] [Full Text] [Related]
44. [Extend screening for cervical cancer! Improved diagnosis with papillomavirus test and colposcopy].
Rubinstein E
Lakartidningen; 1996 Jan; 93(5):365-6, 369. PubMed ID: 8628068
[No Abstract] [Full Text] [Related]
45. Cervical human papillomavirus screening among older women.
Grainge MJ; Seth R; Guo L; Neal KR; Coupland C; Vryenhoef P; Johnson J; Jenkins D
Emerg Infect Dis; 2005 Nov; 11(11):1680-5. PubMed ID: 16318718
[TBL] [Abstract][Full Text] [Related]
46. Editorial: Recent Advances in Molecular Detection of Human Papillomavirus and Cervical Cancer Screening.
Poljak M; Ginocchio CC
J Clin Virol; 2016 Mar; 76 Suppl 1():S1-S2. PubMed ID: 26597652
[No Abstract] [Full Text] [Related]
47. Adding a test for human papillomavirus DNA to cervical-cancer screening.
Wright TC; Schiffman M
N Engl J Med; 2003 Feb; 348(6):489-90. PubMed ID: 12571255
[No Abstract] [Full Text] [Related]
48. The role of human papillomavirus testing in cervical cancer screening.
Morasse L; Davidov A; Castellanos MR
JAAPA; 2009 Nov; 22(11):20-3. PubMed ID: 19999172
[No Abstract] [Full Text] [Related]
49. [Strong connection between papillomavirus and cervix cancer. More precise cytology is needed, cancer transformation may occur rapidly].
Ylitalo N; Pontén J
Lakartidningen; 1998 Apr; 95(15):1632-6. PubMed ID: 9599461
[No Abstract] [Full Text] [Related]
50. Guidelines recommend less frequent screening interval for cervical cancer.
Twombly R
J Natl Cancer Inst; 2003 Mar; 95(6):424-5. PubMed ID: 12644532
[No Abstract] [Full Text] [Related]
51. [New guidelines for prevention of cervix cancer. ARG report on investigation and treatment of abnormal cytological smears].
Strander B; Elfgren K; Andrae B
Lakartidningen; 2011 Mar 9-15; 108(10):533-5. PubMed ID: 21744553
[No Abstract] [Full Text] [Related]
52. Human papillomavirus testing as a screening tool for cervical cancer.
Koss LG
JAMA; 2000 May; 283(19):2525-6. PubMed ID: 10815110
[No Abstract] [Full Text] [Related]
53. The Impact and Burden of Human Papillomavirus-Associated Disease.
Ducatman BS
Arch Pathol Lab Med; 2018 Jun; 142(6):686-687. PubMed ID: 29848033
[No Abstract] [Full Text] [Related]
54. Update on cervical cancer screening. Current diagnostic and evidence-based management protocols.
Ball C; Madden JE
Postgrad Med; 2003 Feb; 113(2):59-64, 70. PubMed ID: 12611115
[TBL] [Abstract][Full Text] [Related]
55. Cervical cancer screening.
Burns R
Cleve Clin J Med; 2005 Apr; 72(4):272; author reply 272. PubMed ID: 15850238
[No Abstract] [Full Text] [Related]
56. Commentary on statement on human papillomavirus test utilization.
Cox JT; Moriarty AT; Castle PE
Arch Pathol Lab Med; 2009 Aug; 133(8):1192-4. PubMed ID: 19653706
[No Abstract] [Full Text] [Related]
57. It Is Time to Switch to Primary HPV Screening for Cervical Cancer.
Harper DM; Bettcher CM; Young AP
Am Fam Physician; 2024 Jan; 109(1):8-9. PubMed ID: 38227863
[No Abstract] [Full Text] [Related]
58. Reasons for rejection of self-collected samples for cervical screening.
Brotherton JM; Hawkes D; Saville M
Med J Aust; 2022 Mar; 216(4):214. PubMed ID: 35148569
[No Abstract] [Full Text] [Related]
59. AWHONN partners with national cervical cancer campaign.
AWHONN Lifelines; 2002; 6(2):163-4. PubMed ID: 11975131
[No Abstract] [Full Text] [Related]
60. Cervical cancer can be controlled.
Rogo KO
East Afr Med J; 2001 Feb; 78(2):53-4. PubMed ID: 11682944
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
